 |
|
Normalizing tumor vessels to improve cancer therapy
August 26, 2008Researchers explore why tumor blood vessels are abnormal and leaky
Chemotherapy drugs often never reach the tumors they're intended to treat, and radiation therapy is not always effective, because the blood vessels feeding the tumors are abnormal-"leaky and twisty" in the words of the late Judah Folkman, MD, founder of the Vascular Biology program at Children's Hospital Boston. Now, Vascular Biology researchers have discovered an explanation for these abnormalities that could, down the road, improve chemotherapy drug delivery. Their findings were published in the August 12 issue of the Proceedings of the National Academy of Sciences.
A tumor's capillaries-small blood vessels that directly deliver oxygen and nutrients to cancer cells-are irregularly shaped, being excessively thin in some areas and forming thick, snarly clumps in others. These malformations create a turbulent, uneven blood flow, so that too much blood goes to one region of the tumor, and too little to another. In addition, the capillary endothelial cells lining the inner surface of tumor capillaries, normally a smooth, tightly-packed sheet, have gaps between them, causing vessel leakiness.
"These abnormal features of tumor vessels impair delivery of circulating chemotherapeutic drugs to the actual tumor site" says Kaustabh Ghosh, PhD, first author on the paper, and a postdoctoral fellow in the laboratory of Donald Ingber, MD, PhD, the paper's senior author and interim co-director of the Vascular Biology program.
The idea of a therapy aimed at normalizing a tumor's blood vessels, to ensure that chemotherapeutic agents reach the tumor, has already been explored, but these attempts have only targeted soluble factors, particularly vascular endothelial growth factor (VEGF). Tumors secrete VEGF in abundance; it not only promotes blood vessel growth (angiogenesis), but makes them leaky. While blocking VEGF action helps reduce leakiness and improves vessel function, the effects have been transient, Ghosh says.
Ghosh and Ingber took a different approach, focusing on the role of mechanical forces on tumor blood vessels, which had previously been ignored. Past studies by Ingber and colleagues have shown that a capillary cell's sensitivity to soluble angiogenic factors like VEGF-and subsequent blood vessel formation-are determined by the mechanical balance between the cell's internal state of tension or contraction, and that of the surrounding support structure, or matrix, to which the cell adheres. These forces guide normal vascular pattern formation. Because tumor vessels are malformed, Ghosh wondered whether tumor capillary cells have lost the normal cells' ability to sense and respond to changes in matrix stiffness and distortion.
To address this question, the researchers studied capillary cells isolated from mice prostate tumors, provided by Andrew Dudley, PhD, in the lab of Michael Klagsbrun, PhD, in the Vascular Biology Program, and exposed them to cyclic mechanical stress-mimicking the pulsatile nature of blood flow and matrix distortion resulting from rhythmic heart beats. They found that normal capillary cells aligned themselves uniformly perpendicular to the force direction, but most of the tumor capillary cells failed to reorient, says Ghosh. These cells were "all over the place," and due to this lack of alignment, gaps appeared between neighboring cells, which may explain the increased vessel permeability.
Ghosh and colleagues also found that tumor capillary cells sense and respond to matrix rigidity differently than normal cells. When placed on a stiff surface, mimicking the tumor matrix, the cells tended to keep spreading even after normal capillary cells stopped doing so. Because of these differences in "mechanosensing," the tumor capillary cells were able to form capillaries even when cell densities were very low, while normal cells failed to do so. At higher cell densities, normal cells formed nice capillaries, whereas the tumor cells balled up into tangled clumps, creating the irregular patterns seen in many images of tumor blood vessels. "Because high cell density increases contractility across the entire cell layer, these findings suggested that tumor capillary cells are inherently hyper-contractile," says Ghosh.
The researchers went on to find that this hyper-contractility results from an increase in the levels of a protein called Rho-associated kinase (ROCK), which controls tension within the cell. When they treated tumor capillary cells with an inhibitor of ROCK, they normalized the behavior of the tumor capillary cells, so that the treated cells exhibited near-normal mechanical responses and formed more regularly-shaped tubular vessels.
"In this study, we've uncovered a previously unrecognized role for tumor capillary cell mechanosensing and contractility in the formation of irregular tumor vessels, and have identified potential new targets for vascular normalization therapy that might be implemented in the clinic someday," Ghosh says.
Children's Hospital Boston
"These abnormal features of tumor vessels impair delivery of circulating chemotherapeutic drugs to the actual tumor site" says Kaustabh Ghosh, PhD, first author on the paper, and a postdoctoral fellow in the laboratory of Donald Ingber, MD, PhD, the paper's senior author and interim co-director of the Vascular Biology program.
The idea of a therapy aimed at normalizing a tumor's blood vessels, to ensure that chemotherapeutic agents reach the tumor, has already been explored, but these attempts have only targeted soluble factors, particularly vascular endothelial growth factor (VEGF). Tumors secrete VEGF in abundance; it not only promotes blood vessel growth (angiogenesis), but makes them leaky. While blocking VEGF action helps reduce leakiness and improves vessel function, the effects have been transient, Ghosh says.
Ghosh and Ingber took a different approach, focusing on the role of mechanical forces on tumor blood vessels, which had previously been ignored. Past studies by Ingber and colleagues have shown that a capillary cell's sensitivity to soluble angiogenic factors like VEGF-and subsequent blood vessel formation-are determined by the mechanical balance between the cell's internal state of tension or contraction, and that of the surrounding support structure, or matrix, to which the cell adheres. These forces guide normal vascular pattern formation. Because tumor vessels are malformed, Ghosh wondered whether tumor capillary cells have lost the normal cells' ability to sense and respond to changes in matrix stiffness and distortion.
To address this question, the researchers studied capillary cells isolated from mice prostate tumors, provided by Andrew Dudley, PhD, in the lab of Michael Klagsbrun, PhD, in the Vascular Biology Program, and exposed them to cyclic mechanical stress-mimicking the pulsatile nature of blood flow and matrix distortion resulting from rhythmic heart beats. They found that normal capillary cells aligned themselves uniformly perpendicular to the force direction, but most of the tumor capillary cells failed to reorient, says Ghosh. These cells were "all over the place," and due to this lack of alignment, gaps appeared between neighboring cells, which may explain the increased vessel permeability.
Ghosh and colleagues also found that tumor capillary cells sense and respond to matrix rigidity differently than normal cells. When placed on a stiff surface, mimicking the tumor matrix, the cells tended to keep spreading even after normal capillary cells stopped doing so. Because of these differences in "mechanosensing," the tumor capillary cells were able to form capillaries even when cell densities were very low, while normal cells failed to do so. At higher cell densities, normal cells formed nice capillaries, whereas the tumor cells balled up into tangled clumps, creating the irregular patterns seen in many images of tumor blood vessels. "Because high cell density increases contractility across the entire cell layer, these findings suggested that tumor capillary cells are inherently hyper-contractile," says Ghosh.
The researchers went on to find that this hyper-contractility results from an increase in the levels of a protein called Rho-associated kinase (ROCK), which controls tension within the cell. When they treated tumor capillary cells with an inhibitor of ROCK, they normalized the behavior of the tumor capillary cells, so that the treated cells exhibited near-normal mechanical responses and formed more regularly-shaped tubular vessels.
"In this study, we've uncovered a previously unrecognized role for tumor capillary cell mechanosensing and contractility in the formation of irregular tumor vessels, and have identified potential new targets for vascular normalization therapy that might be implemented in the clinic someday," Ghosh says.
Children's Hospital Boston
Vascular Biology Current Events and Vascular Biology News RSSReceptor could halt blinding diseases, stop tumor growth, preserve neurons after trauma
An international team of researchers has discovered what promises to be the on-off switch behind several major diseases.
LIAI launches new division to look at novel approaches to heart disease and inflammation
While cholesterol-lowering drugs and new technologies have significantly advanced the nation's battle against heart disease, it continues to rank as the No. 1 killer of U.S. men and women. But if researchers at the La Jolla Institute for Allergy & Immunology (LIAI) have their way, the body's immune system will become an important player in reducing heart disease.
Healthy blood vessels may prevent fat growth
The cells lining blood vessels are known to be important for maintaining health, but researchers at the Indiana University School of Medicine believe these cells may perform an unsuspected task - controlling the development of fat cells.
New oral angiogenesis inhibitor offers potential nontoxic therapy for a wide range of cancers
The first oral, broad-spectrum angiogenesis inhibitor, specially formulated through nanotechnology, shows promising anticancer results in mice, report researchers from Children's Hospital Boston.
Many paths, few destinations: How stem cells decide what they'll be
How does a stem cell decide what specialized identity to adopt - or simply to remain a stem cell? A new study suggests that the conventional view, which assumes that cells are "instructed" to progress along prescribed signaling pathways, is too simplistic.
Human vascular system in mice
The formation of new blood vessels, or angiogenesis, is an Achilles' heel of tumor growth, because tumors depend on the supply of oxygen and nutrients for survival.
New guidelines issued for treating resistant hypertension
For the first time, the American Heart Association has issued guidelines to help patients and healthcare providers tackle resistant high blood pressure that seems to defy treatment.
Lung damage in babies with congenital heart disease under study
Trying to understand and stop the collateral lung damage that can occur in babies with congenital heart disease is the focus of a new study.
Key Found to Breakthrough Drug for Clot Victims
A team of researchers at Oregon Health & Science University and Washington University in St. Louis have described for the first time the mechanism that gives a mutant enzyme molecule that they have engineered - and patented - the potential to become a breakthrough drug for treating heart attacks and strokes.
Adult stem cell application effective in treatment of peripheric vascular disease
Multipotent adult progenitor stem cells extracted from bone marrow, and known as MAPCs, have proved to be effective in the regeneration of blood vessel tissue and also in muscle tissue when treating peripheric vascular disease.
More Vascular Biology Current Events and Vascular Biology News Articles
| Biology of Aquatic Vascular Plants by C. Duncan Sculthorpe | |
| Morphology and Evolution of Vascular Plants (A Series of Books in Biology) by Ernest M. Gifford, Adriance S. Foster | |
 | Introduction to Vascular Biology: From Basic Science to Clinical Practice This updated and expanded new edition takes full account of recent developments and conveys the basic science underlying a wide range of clinical conditions including atherosclerosis, hypertension, diabetes, and pregnancy. As with the first edition, the publication provides an introductory account of vascular biology before leading on to explain mechanisms involved in disease processes. The... |
 | Vascular Medicine: A Textbook of Vascular Biology and Diseases For physicians seeking a single resource on all aspects of vascular derangements--from foundations, to diagnosis, to medical and invasive management--this is the only choice. Vascular surgeons and cardiology fellows alike will prize its unique coverage of basic sciences. Edited by the most well-known and respected practitioners in the field, the book is divided into five major sections:... |
 | Developmental Vascular Biology, Volume 62 (Current Topics in Developmental Biology) Current Topics in Developmental Biology provides a comprehensive survey of the major topics in the field of developmental biology. The volumes are valuable to researchers in animal and plant development, as well as to students and professionals who want an introduction to cellular and molecular mechanisms of development. The series has recently passed its 30-year mark, making it the... |
 | Vascular Biology Protocols (Methods in Molecular Medicine) Over the past decades, the pathogenesis, diagnosis, treatment and prevention of cardiovascular diseases have been benefited significantly from intensive research activities. In order to provide a comprehensive “manual” in a field that has become as broad and deep as cardiovascular medicine, this volume of “Methods in Molecular Medicine” covers a wide spectrum of in vivo and in vitro... |
 | Methods in Endothelial Cell Biology (Springer Lab Manuals) Endothelial cell biology has developed into a vibrant discipline and has become a critical instrument to study several disease processes on the cellular and molecular level. It is now widely recognized that dysfunctions of normal endothelial cell homeostasis are involved in some of the most important human diseases, including ischemic heart diseases, hypertension, atherosclerosis, tumors,... |
 | The Radiation Biology of the Vascular Endothelium by David B. Rubin Endothelial cells are early targets of radiation injury. Because these cells are tissues easily damaged by radiation, if we can understand the causes of radiation injury, then normal cells can be well protected and tumors can be destroyed. The Radiation Biology of the Vascular Endothelium brings together expert reviews on the biology and radiobiology of the vasculature, with emphasis on the... |
| Novel protein linked to heart risk.(Indiana Center for Vascular Biology and Medicine): An article from: Medical Update This digital document is an article from Medical Update, published by Benjamin Franklin Literary & Medical Society, Inc. on July 1, 2004. The length of the article is 461 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web... | |
 | New Advances In Vascular Biology & Molecular Cardiovascular Medicine by Debra A. Schwinn (Society of Cardiovascular Anesthesiologists) Review of basic vascular biology ranging from gene therapy approaches to modifying vascular disease. For cardiologists, cardiac and vascular surgeons, cardiac anesthetists, and... |
| © 2008 BrightSurf.com |